3i, LP - 01 Jul 2025 SCHEDULE 13G Report for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (CHRO)

Filing Manager
3i, LP
Reporting Manager
3i, LP
Security
Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol
CHRO
Shares outstanding
3,062,000 shares
Disclosed Ownership
303,138 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
08 Jul 2025, 16:05:35 UTC
Date of event
01 Jul 2025
Next filing
05 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
3i, LP 9.9% 303,138 0 303,138 /s/ 3i, LP Maier Joshua Tarlow, Manager of 3i Management LLC, General Partner of 3i, LP
3i Management LLC 9.9% 303,138 0 303,138 /s/ 3i Management LLC Maier Joshua Tarlow, Manager
Maier Joshua Tarlow 9.9% 303,138 0 303,138 /s/ Maier Joshua Tarlow Maier Joshua Tarlow